TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
INGN

Inogen Inc

Healthcare · Medical Devices

5.80$ -2.9% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Inogen Inc (INGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 286 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet INGN
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
195 214 228 251 270 275 300 333 357 376 388 404 445 447 459 458 460 462 476 498 513 490 475 470 470 405 386 374 344 326 316 309 306 296 308 312 307 299 286 286
158 162 177 199 220 228 251 283 300 315 322 341 290 292 303 303 303 306 310 328 336 329 318 315 318 305 283 269 225 207 199 195 193 185 201 203 204 198 191 194
86 93 105 115 130 143 154 166 176 197 190 214 156 198 208 214 214 212 220 239 242 236 213 224 210 187 164 168 125 125 107 98 106 114 119 104 108 104 94 87
108 114 128 144 163 174 188 208 224 240 239 256 201 209 208 219 221 231 233 250 245 246 223 224 210 187 175 170 138 128 120 118 121 114 119 122 125 120 111 106
31 31 31 36 36 33 36 40 37 40 44 49 44 37 43 31 35 32 40 39 35 26 35 33 52 64 56 53 49 42 41 37 35 30 37 39 40 39 42 46
16 14 14 16 17 19 23 27 31 27 29 24 34 36 38 36 29 25 26 27 32 32 34 33 36 34 39 31 24 22 25 24 23 25 26 24 25 26 25 29
27 25 24 22 21 20 21 22 23 22 22 21 20 19 20 22 25 28 31 61 37 39 39 64 41 43 46 69 – – – – – – – – – – – –
0.0 0.0 0.0 2.3 2.3 2.4 2.4 2.3 2.3 2.3 2.2 2.2 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 9.9 10 9.8 9.8 10 9.5 9.9 11 11 11 10 10
0.3 0.2 0.2 1.7 1.7 4.7 4.5 4.1 4.1 3.8 3.4 3.1 80 78 75 73 71 69 67 64 62 60 58 56 54 0.2 – – 34 35 33 34 34 30 32 33 32 31 29 27
39 32 35 43 49 48 54 66 66 65 66 70 102 103 112 107 108 112 120 127 122 119 116 114 119 108 104 100 113 121 124 121 121 122 110 113 110 106 103 111
30 23 25 32 35 34 38 47 46 47 44 46 50 50 56 51 52 57 55 62 60 62 60 59 66 65 63 59 60 72 74 72 72 77 65 67 65 64 61 71
0.1 7.1 – – – 11 – – – 13 2.1 2.0 2.2 2.0 1.9 1.8 1.9 1.9 2.5 3.6 3.5 3.4 3.4 3.5 3.5 3.5 3.6 3.6 3.9 3.7 3.5 3.3 2.8 2.8 2.9 3.1 3.1 3.2 3.5 3.3
10 13 8.9 12 11 21 14 18 13 27 14 16 18 16 19 13 9.5 13 15 16 16 10 18 12 21 18 18 13 15 0.0 16 15 15 17 23 22 34 20 31 25
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 4.9 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
156 182 193 208 221 227 246 267 291 310 322 334 343 345 347 351 353 350 356 371 391 370 358 357 351 297 281 275 231 205 192 188 185 174 198 199 197 192 183 175
-34 -12 -6.4 1.9 9.2 8.6 19 34 50 60 66 76 83 81 80 82 81 76 75 80 92 69 55 52 42 -15 -35 -45 -90 -117 -132 -137 -143 -153 -159 -163 -168 -176 -184 -188
21 21 22 22 22 22 22 23 23 23 23 22 22 22 22 22 22 22 22 23 23 23 23 23 23 23 23 23 23 23 23 24 24 24 25 27 26 27 27 27

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?